What is he best known for?
The fields of study he is best known for:
- Dopamine
- Internal medicine
- Neurotransmitter
The scientist’s investigation covers issues in Dopamine, Endocrinology, Internal medicine, Nucleus accumbens and Pharmacology.
His research in Dopamine tackles topics such as Nicotine which are related to areas like Nicotinic agonist and Mecamylamine.
He studied Endocrinology and Serotonin that intersect with Signal transduction.
His work deals with themes such as Striatum, Prefrontal cortex and Neurotransmitter, which intersect with Nucleus accumbens.
His Pharmacology research is multidisciplinary, incorporating perspectives in Psychotomimetic, Agonist, Cannabinoid receptor, Amphetamine and Cannabinoid.
In his work, Ibotenic acid is strongly intertwined with Glutamate receptor, which is a subfield of Neuroscience.
His most cited work include:
- Characterization of a Novel Endocannabinoid, Virodhamine, With Antagonist Activity at the CB1 Receptor (514 citations)
- Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area (471 citations)
- Alterations in 5-HT1B Receptor Function by p11 in Depression-Like States (464 citations)
What are the main themes of his work throughout his whole career to date?
George G. Nomikos spends much of his time researching Internal medicine, Endocrinology, Pharmacology, Dopamine and Neuroscience.
Endocrinology and Serotonin are commonly linked in his work.
His studies in Pharmacology integrate themes in fields like Dopamine receptor D2, Cannabinoid, Antagonist, Receptor and Cannabinoid receptor.
His study explores the link between Dopamine and topics such as Nicotine that cross with problems in Nicotinic agonist and Mecamylamine.
His work carried out in the field of Neuroscience brings together such families of science as Glutamate receptor and Postsynaptic potential.
The study incorporates disciplines such as Dizocilpine, Basal ganglia, Prefrontal cortex and Dopamine receptor D1 in addition to Nucleus accumbens.
He most often published in these fields:
- Internal medicine (56.33%)
- Endocrinology (50.22%)
- Pharmacology (41.92%)
What were the highlights of his more recent work (between 2013-2021)?
- Major depressive disorder (8.30%)
- Vortioxetine (6.99%)
- Internal medicine (56.33%)
In recent papers he was focusing on the following fields of study:
George G. Nomikos mainly investigates Major depressive disorder, Vortioxetine, Internal medicine, Pharmacology and Placebo.
As a part of the same scientific family, George G. Nomikos mostly works in the field of Major depressive disorder, focusing on Rating scale and, on occasion, Digit symbol substitution test, Beck Depression Inventory and Subgroup analysis.
His research in Vortioxetine intersects with topics in Duloxetine, Cognition, Major depressive episode and Clinical psychology.
As a part of the same scientific study, George G. Nomikos usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Cannabinoid.
George G. Nomikos has included themes like Receptor, Anxiolytic and Dopamine in his Pharmacology study.
His Placebo research is multidisciplinary, incorporating elements of Tolerability, Adverse effect and Dosing.
Between 2013 and 2021, his most popular works were:
- Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. (137 citations)
- The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies (62 citations)
- Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. (33 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Dopamine
- Neurotransmitter
Major depressive disorder, Pharmacology, Vortioxetine, Internal medicine and Pharmacokinetics are his primary areas of study.
Many of his studies on Pharmacology involve topics that are commonly interrelated, such as Placebo.
His Vortioxetine study incorporates themes from Duloxetine, Montgomery–Åsberg Depression Rating Scale, Major depressive episode and Clinical psychology.
He combines subjects such as Beck Depression Inventory, Anxiety, Digit symbol substitution test and Rating scale with his study of Clinical psychology.
Much of his study explores Internal medicine relationship to Endocrinology.
His work on Pharmacodynamics as part of general Pharmacokinetics research is frequently linked to Bupropion, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
